« Back
A Novel Anti-LAG3 Monoclonal Antibody
Poster Title: A Novel Anti-LAG3 Monoclonal Antibody
Submitted on 01 Dec 2020
Author(s): Protheragen
Poster Views: 171
View poster »

Poster Information
Abstract: Anti-LAG3 mAb is a monoclonal antibody targets lymphocyte activating 3 (LAG3) that involves in T cell immune regulation. Anti-LAG3 mAb as an antagonistic antibody removes LAG3 mediated T cell inhibition to make nonspecific immune activation, for the treatment of various solid tumors and hematologic cancers.Summary: Anti-LAG3 mAb differs from the leading competitor (monoclonal antibody 25F7 from Bristol Myers Squibb) with different epitope and higher affinity. Its optimal safety and efficacy can ensure its market share.References: abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons